OakChart

Auna SA

AUNAHealthcare·Medical Care Facilities·Luxembourg·Small·NYSE·Nov 11 • 9:35 AM ET

4.59-0.01 (-0.13%)
2026-11-11 15:35 CET
Market cap
340.46 USD m
Revenue, TTM
1,359.29 USD m
Net income, TTM
4.08 USD m
Free cash flow, TTM
117.73 USD m
EPS diluted, TTM
0.05
P/E
84.14
Compare

Price

AUNA against its 20, 50 and 200-day averages
2050200missearnings
4.004.505.005.50567K1.1MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AUNAclose 4.5920-day 4.8950-day 5.04200-day 5.104.59

27.0% under 6.29 on 11 Mar 2026. Last 15 sessions, 19.5% high to low

Profile

AUNA
52-week range, 23% of the way up
4.096.29

Auna SA engages in the provision of healthcare and medical services. It operates through the following segments: Oncosalud Peru, Healthcare Services in Peru, and Healthcare Services in Colombia. The Oncosalud Peru segment offers prepaid oncology plans and oncology services provided at Oncosalud facilities. The Healthcare Services in Peru segment provides medical services in Peru. The Healthcare Services in Colombia segment manages and operates medical centers in Colombia. The company was founded on November 4, 2008 and is headquartered in Luxembourg.

Employees15254
IPOMar 22, 2024
Beta0.64
ATR, 14d0.17
Rel volume0.56
Short float2.23%
Insider own63.25%
Inst own25.34%

Snapshot

6 groups

Valuation

Index-
Market Cap340.00M
Enterprise Value1.35B
Income4.08M
Sales1.36B
Book/sh7.37
Cash/sh1.91
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees15254
IPOMar 22, 2024

Ratios

P/E84.14
Forward P/E4.58
PEG-
P/S0.25
P/B0.62
P/C2.41
P/FCF2.89
EV/EBITDA5.69
EV/Sales0.99
Quick Ratio1.00
Current Ratio1.08
Debt/Eq2.01
LT Debt/Eq1.77
Option/ShortNo / Yes

Earnings

EPS (ttm)0.05
EPS next Y1.00
EPS next Q0.26
EPS this Y-40.31%
EPS next Y31.49%
EPS next 5Y-0.46%
EPS past 3/5Y- -
Sales past 3/5Y24.37% 24.38%
EPS Y/Y TTM-93.67%
Sales Y/Y TTM16.82%
EPS Q/Q-61.75%
Sales Q/Q20.64%
EarningsNov 17 AMC
EPS/Sales Surpr.-44.24% 2.57%

Ownership

Insider Own63.25%
Insider Trans0.14%
Inst Own25.34%
Inst Trans-2.12%
ROA0.19%
ROE0.81%
ROIC0.27%
Gross Margin36.89%
Oper. Margin12.51%
Profit Margin0.30%
SMA20-6.02%
SMA50-8.92%
SMA200-9.93%
Trades-

Technical

Shs Outstand30.10M
Shs Float27.20M
Short Float2.23%
Short Ratio3.51
Short Interest0.61M
52W High6.29 -26.97%
52W Low4.09 12.32%
Volatility3.59% 3.87%
ATR (14)0.17
RSI (14)37.47
Beta0.64
Rel Volume0.56
Avg Volume172.80K
Volume6,008

Performance

Perf Week-0.78%
Perf Month-13.81%
Perf Quarter-13.16%
Perf Half Y-6.06%
Perf YTD-6.63%
Perf Year-12.00%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.40
Target Price7.54
Prev Close4.60
Price4.59
Change %-0.13%

Analyst ratings

latest 7 of 7
DateActionAnalystRating changeTargetImplied
Jan 21, 2026UpgradeHHSBC SecuritiesHold → Buy$6.90+50.2%
Jan 16, 2026InitiatedJJefferiesBuy$9+95.9%
Nov 18, 2025DowngradeJJP MorganOverweight → Neutral$6+30.6%
May 22, 2025DowngradeHHSBC SecuritiesBuy → Hold$7.90+72.0%
Apr 23, 2024InitiatedHHSBC SecuritiesBuy$12.60+174.3%
Apr 16, 2024InitiatedMMorgan StanleyOverweight$14+204.8%
Apr 16, 2024InitiatedJJP MorganOverweight$16+248.3%

Peers

Mkt cap
TickerCompanyMkt cap
CYHCommunity Health Systems Inc305.32M
HCAHCA Healthcare Inc105.09B
STLNStarling Oncology Inc453.35M
ARDTArdent Health Inc2.52B
THCTenet Healthcare Corp22.93B
UHSUniversal Health Services Inc11.16B
ASTHAstrana Health Inc1.61B
FMSFresenius Medical Care AG ADR11.75B
UNHUnitedhealth Group Inc360.58B
AFYAAfya Ltd970.32M

Insider trading

8 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Zamora Leon JesusPresidentMay 26 '26Buy4.3930,000131,70045,914Jun 01 08:48 PM
Zamora Leon JesusPresidentMay 28 '26Buy4.179,22038,44755,134Jun 01 08:48 PM
Zamora Leon JesusPresidentMay 29 '26Buy4.156,42026,64369,130Jun 01 08:48 PM
Zamora Leon JesusPresidentMay 20 '26Buy4.395,81425,52315,914Jun 01 08:48 PM
Wilton JohnDirectorMay 28 '26Sale4.1717,57473,30349,974Jun 01 08:46 PM
Zamora Leon JesusPresidentMay 27 '26Buy4.2023,27397,70262,710May 28 09:05 PM
Zamora Leon JesusPresidentMay 26 '26Buy4.248,72736,99339,437May 28 09:05 PM
Wilton JohnDirectorMay 28 '26Proposed Sale4.2017,57473,810May 28 04:34 PM

Held by

AUM
TickerCompanyAUM
EPUiShares MSCI Peru and Global Exposure ETFAUM: 502.77M

News

latest 14 of 196
  • Auna's Third Quarter Must Prove Margin Recovery Can Catch Up With Solid Revenue (Earnings Whispers)
  • Auna stock tumbles as company slashes 2026 EBITDA guidance (Investing.com) -7.02%
  • Auna Announces Preliminary Update to Full-Year 2026 Outlook (Business Wire)
  • Auna Announces Reporting Dates for Third Quarter 2026 Financial Results (Business Wire)
  • Auna to Host 2026 Investor Day on October 22, 2026 (Business Wire)
  • Loading…
  • Auna SA (AUNA) (Q2 2026) Earnings Call Highlights: Revenue Climbs 9% on Volume Growth, but ... (GuruFocus.com)
  • Auna Announces 2Q26 Financial Results (Business Wire)
  • Auna Announces Reporting Dates for Second Quarter 2026 Financial Results (Business Wire)
  • Auna SA (AUNA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Margin Challenges (GuruFocus.com) -7.79%
  • Auna Announces 1Q26 Financial Results (Business Wire)
  • Auna Announces the Filing of Its Form 20 F for the Fiscal Year 2025 (Business Wire)
  • Auna Reports Preliminary Key Performance Indicators for the First Quarter ended March 31, 2026 (Business Wire)
  • Auna Announces Reporting Dates for First Quarter 2026 Financial Results (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-17-0.265--359.241
2026Q22026-08-180.1490.2660.119367.63358.412
2026Q12026-05-190.0260.1800.026344.04325.51
2025Q42026-03-100.5180.197-0.271329.98325.82
2025Q32025-11-200.2100.1840.183330.5338.153
2025Q22025-08-190.3310.1410.303309.59305.722
2025Q12025-05-200.1900.1640.129282.23093
2024Q42025-03-100.1280.1530.075289.61298.673
2024Q32024-11-190.2580.1870.351297.12307.542
2024Q22024-08-210.0130.1520.014298.01490.283
2024Q12024-05-220.0960.139-0.075289276.793
2026Q4--0.183---1
2027Q1--0.244---1
2027Q2--0.291---1
2027Q3--0.294---1
2027Q4--0.209---1

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2023FY-1.023--1.5451,038-
2024FY0.5370.5320.4351,1951,197
2025FY1.2700.8500.3841,2771,288
2026FY-0.764--1,442
2027FY-1.004--1,526
2028FY-1.262--1,672
2029FY-1.275--1,715
2030FY-1.375--1,784

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-19200359.24359.07359.42
2026Q3S2026-10-13100359.47359.47359.47
2026Q3S2026-08-19100360.74360.74360.74
2026Q3S2026-05-25100357.59357.59357.59
2026Q3S2026-03-11100350.5350.5350.5
2026Q3S2026-02-04100357.64357.64357.64
2026Q3R2026-08-191000.270.270.27
2026Q3R2026-06-091000.260.260.26
2026Q3R2026-05-221100.270.270.27
2026Q3R2025-11-211000.240.240.24
2026Q3R2025-11-171000.240.240.24
2026Q3E2026-10-171000.260.260.26
2026Q3E2026-09-021010.270.270.27
2026Q3E2026-08-192010.270.270.27

Estimate history

EPS, annual0.1540.2510.496-0.046-0.155-0.508-1.5450.4350.370.0546
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0140.3510.0750.1290.3030.183-0.2710.0260.116
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual221.682262.013414.257412.995495.004639.0981035.4741168.3661229.4231359.29
Period201720182019202020212022202320242025TTM
Sales, quarterly299.449299.747283.011281.635299.231316.067334.719347.508361
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual43.91843.91843.91843.91843.91843.91843.91873.9774.01374.013
Period201720182019202020212022202320242025MRQ
Shares, quarterly303073.9774.01374.01374.01374.01374.01374.013
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,359.291,229.421,168.371,035.47639.10495.00412.99414.26262.01
Cost of Goods Sold Incl. D&A857.80792.54733.93677.08420.00323.47266.42257.42153.38
Gross Profit501.49436.89434.43358.39219.10171.53146.58156.83108.63
Selling, General and Administrative Excl. Other331.43273.38246.55214.11155.31145.60116.07107.9880.53
Other Operating Expense0.000.000.000.00-0.01-0.01-0.06-0.03-0.17
Operating Income170.06163.51187.88144.2863.7925.9530.5748.8928.27
Interest Expense188.27133.39141.25166.6156.2525.7717.7216.016.96
Unusual Expense0.0047.9515.1047.049.765.535.810.044.56
Net Income Before Taxes19.7052.9446.61-34.85-13.35-1.67-4.1633.7416.19
Income Taxes14.1824.7715.9324.097.665.12-2.2412.345.34
Consolidated Net Income8.4031.0933.02-57.26-20.03-5.92-1.5422.1311.15
Net Income From Continuing Operations4.0827.3729.37-67.84-22.32-6.81-2.0321.7811.01
Net Income4.0827.3729.37-67.84-22.32-6.81-2.0321.7811.01
EPS (Recurring)0.060.820.59-0.79-0.35-0.070.050.500.32
EPS (Basic, Before Extraordinaries)0.050.370.44-1.54-0.51-0.16-0.050.500.25
EPS (Diluted)0.050.370.44-1.54-0.51-0.16-0.050.500.25
EBITDA237.03225.86246.26207.2699.7945.8649.0765.8938.02
Non-Operating Income (Expense)37.9170.7715.0834.51-11.143.68-11.200.90-0.56
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.192.211.71------
Price To Earnings Ratio84.2584.25-------
Price To Sales Ratio0.280.300.40------
Gross Margin36.8935.5437.1834.6134.2834.6535.4937.8641.46
Operating Margin12.5113.3016.0813.939.985.247.4011.8010.79
Net Margin0.302.232.51-6.55-3.49-1.38-0.495.264.20
Shares Outstanding74.0174.0173.9743.9243.9243.9243.9243.9243.92
Market Capitalization340.46340.46205.80201.90-----

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue361.00347.51334.72316.07299.23281.63283.01299.75
Cost of Goods Sold Incl. D&A232.05220.30207.98197.47180.41178.48167.41180.20
Gross Profit128.95127.21126.74118.60118.82103.16115.60119.55
Selling, General and Administrative Excl. Other85.3884.0787.1574.8273.8868.0468.1473.13
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income43.5743.1339.5943.7744.9435.1247.4646.42
Interest Expense34.3734.8986.2632.7532.9033.3134.7336.66
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes16.514.11-27.4726.5535.5315.889.3333.37
Income Taxes7.702.06-7.9812.3913.206.373.587.16
Consolidated Net Income9.532.80-18.9114.9822.9810.266.3526.74
Net Income From Continuing Operations8.581.93-20.0513.6122.429.585.8526.04
Net Income8.581.93-20.0513.6122.429.585.8526.04
EPS (Recurring)0.120.03-0.270.180.300.130.070.35
EPS (Basic, Before Extraordinaries)0.120.03-0.270.180.300.130.080.35
EPS (Diluted)0.120.03-0.270.180.300.130.070.35
EBITDA60.6960.1056.2659.9960.0749.5561.2861.02
Non-Operating Income (Expense)7.31-4.1319.2015.5323.4814.08-3.4123.60
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.610.400.610.570.520.520.541.06
Price To Earnings Ratio84.25-7.087.7910.82---
Price To Sales Ratio0.280.310.300.420.390.450.460.44
Gross Margin35.7236.6137.8637.5239.7136.6340.8539.88
Operating Margin12.0712.4111.8313.8515.0212.4716.7715.49
Net Margin2.380.56-5.994.317.493.402.078.69
Shares Outstanding74.0174.0174.0174.0174.0174.0173.9730.00
Market Capitalization340.46407.81364.14497.37458.88213.30205.80207.30

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments108.7589.4390.2854.7334.7794.9510.9032.8210.03
Short Term Receivables313.91256.03232.52150.5688.37102.4686.2670.4821.59
Inventories49.0138.2735.2522.9715.3214.5311.199.425.53
Other Current Assets76.8869.8060.3585.1329.7419.2225.1319.5210.99
Total Current Assets548.55453.53418.40313.39168.21231.16133.47132.2448.15
Net Property, Plant & Equipment713.77641.80732.60646.25338.59332.71288.94235.21139.24
Total Investments and Advances27.0424.0229.538.5540.157.025.946.620.75
Long-Term Note Receivable0.140.150.110.140.070.10---
Intangible Assets804.24707.20845.13723.46127.79135.71130.35127.7414.80
Deferred Tax Assets68.6151.5145.2032.0528.4321.789.8910.4811.06
Other Assets8.006.505.835.194.304.412.612.781.17
Total Assets2,170.361,884.722,076.801,729.03707.55732.89571.20515.07215.17
Short Term Debt Incl. Current Port. of LT Debt111.41186.23117.64547.4911.6810.2560.6432.2422.16
Accounts Payable313.27247.88202.38134.41111.2293.3375.1070.1530.43
Income Tax Payable20.6626.7526.296.354.585.822.603.281.47
Other Current Liabilities50.4456.93109.9457.8147.5547.2739.8235.0924.37
Total Current Liabilities495.77517.79456.25746.06175.03156.68178.16140.7678.43
Long Term Debt984.48820.08945.95378.26362.44364.29186.05183.7557.69
Provision for Risks Charges2.091.521.881.040.000.000.000.000.00
Deferred Tax Liabilities86.5787.40133.91123.2913.4214.1424.8026.590.83
Other Liabilities76.1625.9458.9971.8119.8617.517.376.110.00
Total Liabilities1,645.071,452.731,596.981,320.47570.75552.62396.39357.21136.96
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity476.05393.20395.74279.27124.24166.13169.82153.2177.79
Total Shareholders Equity476.05393.20395.74279.27124.24166.13169.82153.2177.79
Accumulated Minority Interest49.2538.7984.07129.3012.5514.144.994.660.42
Total Equity525.29431.99479.82408.56136.79180.26174.81157.8678.21
Total Liabilities & Stockholders Equity2,170.361,884.722,076.801,729.03707.55732.89571.20515.07215.17
Book Value Per Share6.435.329.016.362.833.783.873.491.77
Tangible Book Value Per Share-4.43-4.24-10.23-10.11-0.080.690.900.581.43
Full-Time Employees15,25414,84214,958--7,8296,761--
Price to Book Ratio0.620.500.49------
Return on Assets1.351.48-3.56-1.83-0.95-0.314.013.01-
Return on Equity6.307.45-20.42-11.06-4.69-1.2113.489.53-
Return on Invested Capital1.872.42-5.06-3.39-1.40-0.386.123.275.00
Quick Ratio1.010.800.840.390.871.380.690.870.54
Current Ratio1.110.880.920.420.961.480.750.940.61

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income11.6931.0933.02-57.26-20.03-5.92-1.5422.1311.15
Depreciation69.8662.3658.3862.9836.0019.9118.5117.009.75
Other Funds (Non Cash)52.6215.3651.6855.6251.226.3634.8113.625.13
Funds from Operations111.0186.82105.0642.4060.0613.1233.4653.5325.40
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital29.93-14.59-46.24-37.84-45.4812.620.67-19.101.31
Cash from Operating Activities140.9472.2258.824.5614.5825.7334.1334.4326.72
Capital Expenditures-39.10-40.56-37.79-44.12-39.62-74.46-36.88-37.69-14.10
Net Assets From Acquisitions0.000.00-324.35-16.03-769.73-1.010.00-3.82-162.65
Sale of Fixed Assets and Businesses1.901.820.061.12352.650.453.330.000.05
Purchase or Sale of Investments-21.22-5.6819.31-24.640.000.00-0.140.00
Purchase of Investments-0.00-5.68-5.94-24.640.000.00-0.240.00
Sale Or Maturity of Investments-21.220.0025.260.000.000.000.100.00
Other Uses-2.37-5.93-20.56-10.02-3.130.000.000.000.00
Other Sources0.000.000.003.100.000.000.000.000.00
Cash from Investing Activities-6.68-23.45-388.32-46.64-484.46-75.01-33.55-41.65-176.70
Cash Dividends Paid0.000.000.000.000.000.00-2.86-3.00-3.04
Change in Capital Stock0.000.00333.480.000.000.000.000.0073.66
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.00333.480.000.000.000.000.0073.66
Proceedsfrom Stock Options0.000.00333.480.000.000.000.000.0073.66
Issuance or Reduction of Debt, Net-2.9225.9179.42507.748.39116.623.32103.79
Change in Long Term Debt-------0.55-1.18-10.94
Reduction of Long Term Debt-------0.55-1.18-10.94
Net Financing Active Other Cash Flow-16.04-12.72-14.13-15.49-6.93-5.74-1.88-3.190.49
Other Financing Activities Uses-16.04-12.72-14.13-15.49-6.93-5.74-3.72-3.190.00
Cash from Financing Activities-50.37-22.10333.1052.56491.74-4.9686.11-14.65174.90
Exchange Rate Effect3.801.27-5.05-1.82-3.671.571.23-0.54-1.07
Net Change in Cash87.6927.95-1.448.6718.19-52.6787.92-22.4123.84
Free Cash Flow117.7348.1134.62-26.49-12.14-34.298.183.0914.85
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow3.227.5713.37------
Deferred Taxes & Investment Tax Credit--21.99-38.01-18.94-7.14-7.24-18.320.77-0.62

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments141.17122.88108.7593.8980.9181.58
Short Term Receivables335.83324.11313.91310.46286.79277.87
Inventories43.7945.6149.0142.8939.1532.86
Other Current Assets78.0380.5476.8873.8376.5771.91
Total Current Assets598.82573.14548.55521.07483.42464.22
Net Property, Plant & Equipment735.45708.44713.77698.26683.42656.09
Total Investments and Advances27.8429.9427.0421.3222.1225.72
Intangible Assets837.38807.09804.24788.80766.64722.45
Deferred Tax Assets78.5975.8868.6163.8456.5555.15
Other Assets8.187.848.007.707.456.82
Total Assets2,286.392,202.492,170.362,101.142,019.761,930.62
Short Term Debt Incl. Current Port. of LT Debt126.21123.45111.41198.88177.55218.18
Accounts Payable336.44314.38313.27272.90258.83248.67
Income Tax Payable--20.66---
Other Current Liabilities93.9688.4550.44109.3294.0889.18
Total Current Liabilities556.61526.27495.77581.11530.46556.03
Long Term Debt967.76969.59984.48855.66865.80801.70
Provision for Risks Charges0.000.002.090.000.000.00
Deferred Tax Liabilities83.3883.2686.5789.4886.1181.01
Other Liabilities76.8173.7876.1651.1431.2635.58
Total Liabilities1,684.551,652.901,645.071,577.391,513.631,474.33
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity545.35498.08476.05478.32463.07414.71
Total Shareholders Equity545.35498.08476.05478.32463.07414.71
Accumulated Minority Interest56.4951.5149.2545.4343.0741.58
Total Equity601.84549.59525.29523.75506.13456.29
Total Liabilities & Stockholders Equity2,286.392,202.492,170.362,101.142,019.761,930.62
Book Value Per Share7.376.736.436.466.265.60
Tangible Book Value Per Share-3.95-4.18-4.43-4.19-4.10-4.16
Full-Time Employees--15,254---
Price to Book Ratio0.620.850.761.071.110.52
Return on Assets0.190.871.262.563.212.10
Return on Equity0.813.935.8811.6115.049.93
Return on Invested Capital0.570.13-1.371.021.690.79
Quick Ratio1.001.001.010.820.840.78
Current Ratio1.081.091.110.900.910.83

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income9.502.80-16.7416.1323.1110.26
Depreciation16.9116.9718.7417.2415.3014.43
Other Funds (Non Cash)1.2813.7435.022.59-19.02-2.40
Funds from Operations27.6933.5113.8535.9619.3822.29
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital13.413.5713.63-0.68-14.34-13.98
Cash from Operating Activities41.1037.0827.4835.285.048.30
Capital Expenditures-8.83-10.03-10.78-9.45-9.33-13.18
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses-0.000.000.091.820.000.02
Purchase or Sale of Investments4.883.4320.87--0.44
Purchase of Investments0.000.00----
Sale Or Maturity of Investments4.883.4320.87--0.44
Other Uses-1.62-0.12-0.35-0.28-1.13-4.49
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-5.58-6.729.84-4.22-13.11-17.22
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-7.44-6.944.60-11.537.382.63
Net Financing Active Other Cash Flow-6.28-1.37-6.00-2.39-4.75-0.28
Other Financing Activities Uses-6.28-1.37-6.00-2.39-4.70-0.33
Cash from Financing Activities-16.88-11.35-4.87-17.27-0.47-0.69
Exchange Rate Effect1.302.58-0.160.081.210.21
Net Change in Cash19.9421.5932.2913.87-7.32-9.39
Free Cash Flow35.9931.2820.8629.610.56-0.33
Price to Free Cash Flow3.224.957.1813.2014.0424.45

Revenue breakdown

Healthcare services segments2024: 901.53M 2025: 920.68M
Oncosalud Peru2024: 276.83M 2025: 317.83M
Colombia2024: 387.68M 2025: 405.26M
Mexico2024: 320.94M 2025: 293.37M
Peru2024: 469.74M 2025: 539.88M
Healthcare services in Colombia2024: 387.68M 2025: 406.72M
Healthcare services in Mexico2024: 320.94M 2025: 293.37M
Healthcare services in Peru2024: 267.52M 2025: 306.22M
Holding and eliminations2024: -85.40M 2025: -96.62M
Oncosalud Peru2024: 287.63M 2025: 328.81M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.23%0.6M27.2M170.10K
2026-10-151.60%0.4M27.2M152.51K
2026-09-302.14%0.6M27.2M157.38K
2026-09-152.25%0.6M27.2M180.08K
2026-08-312.30%0.6M27.2M224.35K
2026-08-142.13%0.6M27.2M269.77K
2026-07-312.24%0.6M27.2M281.12K
2026-07-152.53%0.7M27.2M301.94K
2026-06-302.59%0.7M27.2M305.99K
2026-06-153.07%0.8M27.2M356.30K
2026-05-293.52%1.0M27.2M394.40K
2026-05-152.64%0.8M29.1M396.38K
2026-04-302.24%0.7M29.1M446.80K
2026-04-152.16%0.6M29.1M497.55K
2026-03-312.58%0.7M27.8M490.79K
2026-03-131.75%0.5M27.8M416.68K
2026-02-271.57%0.4M27.8M340.99K
2026-02-131.12%0.3M27.8M273.50K
2026-01-301.15%0.3M26.1M202.37K
2026-01-151.17%0.3M24.6M129.22K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-27SEC
2026-10-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-22SEC
2026-10-08SCHEDULE 13G/ASEC
2026-08-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-18SEC
2026-08-12SCHEDULE 13G/ASEC
2026-07-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-15SEC
2026-07-09SCHEDULE 13G/ASEC
2026-07-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-07SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-06-013/A2026-03-18SEC
2026-05-29SCHEDULE 13GSEC
2026-05-28144Filing for proposed sale of securities under Rule 144.SEC
2026-05-284Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-27SEC
2026-05-196-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-19SEC
2026-04-22SCHEDULE 13G/ASEC
2026-04-2220-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-12-31SEC
2026-04-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-22SEC
2026-04-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-17SEC
2026-03-253Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-253/A2026-03-18SEC
2026-03-203Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-193Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-193Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-193Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-193Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-05357.01K673.30K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.1.51%
MORGAN STANLEY0.78%
JANE STREET GROUP, LLC0.78%
RENAISSANCE TECHNOLOGIES LLC0.76%
MARSHALL WACE, LLP0.65%
TWO SIGMA INVESTMENTS, LP0.43%
Verde Servicos Internacionais S.A.0.42%
Pekin Hardy Strauss, Inc.0.39%
UBS Group AG0.36%
Mount Lucas Management LP0.24%

Funds

Fund% owned
Eaton Vance Emerging Markets Debt Opportunities Fund19.62%
Global Opportunities Portfolio7.26%
MORGAN STANLEY EMERGING MARKETS DEBT FUND INC0.99%
Emerging Markets Debt Portfolio0.67%
Simplify Gamma Emerging Market Bond ETF0.47%
Man Active High Yield ETF0.41%
iShares Core International Aggregate Bond ETF0.41%
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF0.02%

OakChart. AUNA. Cached 15 minutes.